Skip to main content
SpringerLink
Log in

Leptin and Cardiovascular Disease

  • Chapter
Leptin

Part of the book series: Endocrine Updates ((ENDO,volume 25))

  • 1599 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. B. Hubert, M. Feinleib, P. M. McNaraara, and W. P. Castelli, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation 61, 968–977 (1983).

    Google Scholar 

  2. R. F. Kushner, Body weight and mortality, Nutrit. Rev. 51, 127–136 (1993).

    Article  PubMed  CAS  Google Scholar 

  3. P. G. Kopelman, Obesity as a medical problem. Nature 404, 635–643 (2000).

    PubMed  CAS  Google Scholar 

  4. R. Stamler, J. Stamler, W. F. Riedlinger, G. Algera, and R. H. Roberts, Weight and blood pressure. Findings in hypertension screening of 1 million Americans, JAMA 240, 1607–1610 (1978).

    Article  PubMed  CAS  Google Scholar 

  5. N. Mikhai, and M. L. Tuck, Epidemiological and clinical aspects of obesity related hypertension, J. Clin. Hypertens. (Greenwich) 2, 41–45 (2000).

    Google Scholar 

  6. J. L. Carson, M. E. Ruddy, A. E. Duff, N. J. Holmes, R. P. Cody, and R. E. Brolin, The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch., Intern. Med. 154, 193–200 (1994).

    Article  CAS  Google Scholar 

  7. R. J. Richards, V. Thakur, and E. Reisin, Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment, J. Hum., Hypertens. 10, S59–S64 (1996).

    Google Scholar 

  8. L. N. Kaufman, M. M. Peterson, and S. M. Smith, Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets. Am. J. Physiol. 260, E95~ E100 (1991).

    PubMed  Google Scholar 

  9. E. Mills, CM. Kuhn, M. N. Feinglos, and R. Surwit, Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. Am. J. Physiol 264, R73–R78 (1993).

    PubMed  CAS  Google Scholar 

  10. J. P. Montani, V. Antic Z. Yang, and A. Dulloo, Pathways from obesity to hypertension: from the perspective of a vicious triangle, Intl J. Obes. Relat. Metab., Disord. 26, S28–S38 (2002).

    Article  CAS  Google Scholar 

  11. T. W. Kurtz, R. C. Morris, and H. A. Pershadsingh, The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13, 896–901 (1989).

    PubMed  CAS  Google Scholar 

  12. A. L. Mark, R. A. Shaffer, M. L. Correia, D. A. Morgan, CD. Sigmund, and W. G., Haynes, Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice, J. Hypertens.17, 1949–1953 (1999).

    Google Scholar 

  13. S. Collins, CM. Kuhn, A. E. Petro, A. G. Swick, B. A. Chrunyk, and R. S. Surwit, Role of leptin in fat regulation, Nature 380, 677 (1996).

    Article  PubMed  CAS  Google Scholar 

  14. W. G. Haynes, D. A. Morgan, S. A. Walsh, W. I. Sivitz, and A. L. Mark, Receptor-mediated regional sympathetic nerve activation by leptin, Clin. Invest. 100, 270–278 (1997).

    CAS  Google Scholar 

  15. N. Satoh, Y. Ogawa, G. Katsuura, Y. Numata, T. Tsuji, M. Hayase, K. Ebihara, H. Masuzaki, K. Hosoda, Y. Yoshimasa, and, K. Nakao, Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48, 1787–1793 (1999).

    PubMed  CAS  Google Scholar 

  16. M. Hausberg, D. A. Morgan, M. A. Chapleau, W. I. Sivitz, A. L. Mark, and W. G., Haynes, Differential modulation of leptin-induced sympathoexcitation by baroreflex activation, J. Hypertens. 20, 1633–1641 (2002).

    Article  PubMed  CAS  Google Scholar 

  17. M. Hausberg, D. A. Morgan, J. L. Mitchell, W. I. Sivitz, A. L. Mark, and W. G. Haynes, Leptin potentiates thermogenic sympathetic responses to hypothermia: a receptor-mediated effects. Diabetes 51, 2434–2440 (2002).

    PubMed  CAS  Google Scholar 

  18. A. Niijima, Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat, J. Auton. Nerv. Syst. 27 (73), 19–25 (1998).

    Google Scholar 

  19. M. Tanida, S. Iwashita, Y. Ootsuka, N. Terui, and M. Suzuki, Leptin injection into white adipose tissue elevates renal sympathetic nerve activity dose-dependently through the afferent nerves pathway in rats, Neurosci. Lett. 293, 107–110 (2000).

    Article  PubMed  CAS  Google Scholar 

  20. W. G. Haynes, Interaction between leptin and sympathetic nervous system in hypertension, Curr. Hypertens. Rep. 2, 311–318 (2000).

    PubMed  CAS  Google Scholar 

  21. M. W. Schwartz, S. C. Woods, D. Porte Jr, R. J. Seeley, and D. G. Baskin, Central nervous system control of food intake. Nature 404, 661–671 (2000).

    PubMed  CAS  Google Scholar 

  22. M. Tang-Christensen, P. J. Havel, R. R. Jacobs, P. J. Larsen, and J. L. Cameron, Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques, J. Clin. Endocrinol. Metab. 84, 711–717 (1999).

    Article  PubMed  CAS  Google Scholar 

  23. S. Snitker, R. E. Pratley, M. Nicolson, P. A. Tataranni, and E. Ravussin, Relationship between muscle sympathetic nerve activity and plasma leptin concentration, Obes., Res. 5, 338–340 (1997).

    CAS  Google Scholar 

  24. J. Y. Jeon, R. D. Steadward, G. D, Wheeler, G. Bell, L. McCargar, and V. Harber, Intact sympathetic nervous system is required for leptin effects on resting metabolic rate in people with spinal cord injury, J.Clin. Endocrinol. Metab. 88, 402–407 (2003).

    Article  PubMed  CAS  Google Scholar 

  25. J. R, Sowers, L. A. Whitfield, R. A. Catania, N. Stern, M. L. Tuck, L. Domfeld, and M. Maxwell, Role of the sympathetic nervous system in blood pressure maintenance in obesity, J. Clin. Endocrinol. Metab. 54, 1181–1186 (1982).

    Article  PubMed  CAS  Google Scholar 

  26. J. B. Young, and L. Landsberg, Diet-induced changes in sympathetic nervous system activity: possible implications for obesity and hypertension, J. Chronic Dis. 35, 879–886 (1982).

    Article  PubMed  CAS  Google Scholar 

  27. A. P. Rocchini, C. P. Moorhead, S. Deremer, and D. Bondi, Pathogenesis of weight-related pressure changes in blood pressure in dogs. Hypertension 13, 922–928 (1989).

    Google Scholar 

  28. P. Vollenweider, D. Randin, L. Tappy, E. Jequier, P. Nicod, and U. Scherrer, Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans, J.Clin. Invest. 93, 2365–2371 (1994).

    PubMed  CAS  Google Scholar 

  29. G. Grassi, G. Seravalle, B. M. Cattaneo, G. B. Bolla, A. Lanfranchi, M. Colombo, C. Giannattasio, A. Brunani, P. Cavagnini, and G. Mancia, Sympathetic activation in obese normotensive subjects. Hypertension 25, 560–563 (1995).

    PubMed  CAS  Google Scholar 

  30. M. Vaz, G. Jennings, A. Turner, H. Cox, G. Lambert, and M. Esler, Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96, 3423–3429 (1997).

    PubMed  CAS  Google Scholar 

  31. S. Iwashita, M. Tanida, N. Terui, Y. Ootsuka, M. Shu, D. Kang, and M, Suzuki, Direct measurement of renal sympathetic nervous activity in high-fat diet-related hypertensive rats. Life Set. 71 (5), 537–546 (2002).

    Article  CAS  Google Scholar 

  32. J. E. Hall, D. A. Hildebrandt, J. Kuo, and S. Fitzgerald, Role of sympathetic nervous system and neuropeptides in obesity hypertension, Braz. J. Med. Biol. Res. 33, 605–618 (2000).

    Article  PubMed  CAS  Google Scholar 

  33. R. V. Considine, M. K. Sinha, M. L. Heiman, A. Kriauciunas, T. W. Stephens, M. R., Nyce, J. P. Ghannesian, C. C. Marco, L. J. McKee, T. L. Bauer, and J. F. Caro, Serum immunoreactive-leptin concentrations in normal-weight and obese humans, N. Engl., J. Med 334, 292–295 (1996).

    Article  CAS  Google Scholar 

  34. M. L. Correia, W. G. Haynes, K. Rahmouni, D. A. Morgan, and A. L. Mark, The concept of selective leptin resistance: evidence from agouti yellow obese mice., Diabetes 51, 439–442 (2002).

    PubMed  CAS  Google Scholar 

  35. K. Rahmouni, W. G. Haynes, D. A. Morgan, and A. L. Mark, Selective resistance to central neural administration of leptin in agouti obese mice, Hypertension 39, 486–490 (2002).

    Article  PubMed  CAS  Google Scholar 

  36. N. Eikelis, M. Schlaich, A. Aggarwal, D. Kaye, and M. Esler, Interactions between leptin and tiie human sympathetic nervous system, Hypertension 41, 1072–1079 (2003).

    Article  PubMed  CAS  Google Scholar 

  37. K. Rahmouni, W. G. Haynes, D. A. Morgan, and A. L. Mark, Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin, J. Neurosci. 23 (14), 5998–6004 (2003).

    PubMed  CAS  Google Scholar 

  38. K. D. Niswender, and M. W. Schwartz, Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front., Neuroendocrinol. 24, 1–10 (2003).

    Article  CAS  Google Scholar 

  39. K. Rahmouni, W. G. Haynes, D. A. Morgan, and A. L. Mark, Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 41, 763–767 (2003).

    Article  PubMed  CAS  Google Scholar 

  40. K. Rahmouni, D. A. Morgan, G. A. Morgan, A. L. Mark, and W. G. Haynes, Role of selective leptin in hypertension in diet-induced obesity hypertension. Diabetes 54, pp. 2012–2018 (2005).

    PubMed  CAS  Google Scholar 

  41. W. G. Haynes, D. A. Morgan, A. Djalali, W. I. Sivitz, and A. L. Mark, Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic, Hypertension 33, 542–547 (1999).

    PubMed  CAS  Google Scholar 

  42. J. C. Dunbar, and H. Lu, Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC)products. Brain Res. Bull. 50, 215–221 (1999).

    Article  PubMed  CAS  Google Scholar 

  43. J. Korner, E. Savontaus, S. C. Chua Jr, R. L. Leibel, and S. L. J. Wardlaw, Leptin regulation of Agrp and NPY mRNA in the rat hypothalamus. Neuroendocrinology 13, 959–966 (2001).

    Article  CAS  Google Scholar 

  44. M. L. Correia, D. A. Morgan, J. L. Mitchell, W. I. Sivitz, A. L. Mark, and W. G. Haynes, Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure, Hypertension 38, 384–388 (2001).

    PubMed  CAS  Google Scholar 

  45. G. F. DiBona, and U. C. Kopp, Neural control of renal function, Physiol. Rev. 77, 75–197 (1997).

    PubMed  CAS  Google Scholar 

  46. J. C. Dunbar, Y. Hu, and H. Lu, Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46, 2040–2043 (1997).

    PubMed  CAS  Google Scholar 

  47. E. W. Shek, M. W. Brands, and I. E. Hall, Chronic leptin infusion increases arterial pressure. Hypertension 32, 376–377 (1998).

    Google Scholar 

  48. M. L. Correia, D. A. Morgan, W. I. Sivitz, A. L. Mark, and W. G. Haynes, Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure, Hypertension 37, 936–942 (2001).

    Google Scholar 

  49. M. Carlyle, O. B. Jones, J. J. Kuo, and J. E. Hall, Chronic cardiovascular and renal actions of leptin;role of adrenergic activity. Hypertension 39, 496–501 (2002).

    Article  PubMed  CAS  Google Scholar 

  50. M. Aizawa-Abe, Y. Ogawa, H. Masuzaki, K. Ebihara, N. Satoh, H. Iwai, N. Matsuoka, T. Hayashi, K. Hosoda, G. Inoue, Y. Yoshimasa, and K. Nakao, Pathophysiological role of leptin in obesity-related hypertension, J. Clin. Invest. 105, 1243–1252 (2000).

    Article  PubMed  CAS  Google Scholar 

  51. A. Bouloumie, T. Marumo, M. Lafontan, and R. Busse, Leptin induces oxidative stress in human endothelial cells, FASEB J. 13, 1231–1238 (1999).

    PubMed  CAS  Google Scholar 

  52. S. I. Yamagishi, D. Edelstein, X. L. Du, Y. Kaneda, M. Guzman, and M. Brownlee, Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 276, 25096–25100 (2001).

    Article  PubMed  CAS  Google Scholar 

  53. S. Loffreda, S. Q. Yang, H. Z. Lin, C. L. Karp, M. L. Brengman, D. J. Wang, A. S., Klein, S. Margetic, C. Gazzola, G. G. Pegg, and R. A. Hill, Leptin regulates proinflammatory immune responses. FASEB J. 12, 57–65 (1998).

    PubMed  CAS  Google Scholar 

  54. J. J. Kuo, A. A. Silva, and J. E. Hall, Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function, Hypertension 41, 768–774 (2003).

    Article  PubMed  CAS  Google Scholar 

  55. A. A. Da Silva, J. J. Kuo, and J. E. Hall, Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43, 1312–1317 (2004).

    Article  PubMed  CAS  Google Scholar 

  56. H. Hirose, I. Saito, M. Tsujioka, M. Mori, H. Kawabe, and T. Saruta, The obese gene product, leptin: possible role in obesity-related hypertension in adolescents, J., Hypertens. 16, 2007–2012 (1998).

    Article  CAS  Google Scholar 

  57. U. Schorr, K. Blaschke, S. Turan, A. Distler, and A. M. Sharma, Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men, J. Hypertens. 16, 1475–1480.

    Google Scholar 

  58. K. Itoh, K. Imai, T. Masuda, S. Abe, M. Tanaka, R. Koga, H. Itoh, T. Matsuyama, S. Iwashita, M. Tanida, N. Terui, Y. Ootsuka, M. Shu, D. Kang, and M. Suzuki, Relationship between changes in serum leptin levels and blood pressure after weight loss, Hyperten. Res. 25, 881–886 (2002).

    Article  CAS  Google Scholar 

  59. I. S. Farooqi, S. A. Jebb, G. Langmack, E. Lawrence, C. H. Cheetham, A. M. Prentice, I. A. Hughes, M. A. McCamish, and S. O’Rahilly, Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879–884 (1999).

    Article  PubMed  CAS  Google Scholar 

  60. F. Contreras, M. Rivera, J. Vasquez, M. A. De la Parte, and M. Velasco, Endothelial dysfunction in arterial hypertension, Hum. Hypertens. 14, S20–S25 (2000).

    Article  CAS  Google Scholar 

  61. M. R. Sierra-Honigmann, A. K. Nath, C. Murakami, G. Garcia-Cardena, A., Papapetropoulos, W. C. Sessa, L. A. Madge, J. S. Schechner, M. B. Schwabb, P. J., Polverini, and J. R. Flores-Riveros Jr., Biological action of leptin as an angiogenic factor. Science 28, 1683–1686 (1998).

    Article  Google Scholar 

  62. G. Fruhbeck, Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48, 903–908 (1999).

    PubMed  CAS  Google Scholar 

  63. G. Lembo, C. Vecchione, L. Fratta, G. Marino, V. Trimarco, G. d’Amati, and B., Trimarco, Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 49 (2), 293–297 (2000).

    PubMed  CAS  Google Scholar 

  64. K. Kimura, K. Tsuda, A. Baba, T. Kawabe, S. Boh-oka, M. Ibata, C. Moriwaki, T., Hano, and I. Nishio, Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin, Biochem. Biophys. Res. Commun. 273, 745–749 (2000).

    Article  PubMed  CAS  Google Scholar 

  65. S. M. Gardiner, P. A. Kemp, J. E. March, and T. Bennett, Regional haemodynamic effects of recombinant murine or human leptin in conscious rats, Br. J. Pharmacol. 130, 805–810 (1999).

    Article  Google Scholar 

  66. J. L. Mitchell, D. A. Morgan, M. L. Correia, A. L. Mark, W. I. Sivitz, and W. G., Haynes, Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation? Hypertension 38, 1081–1086 (2001).

    PubMed  CAS  Google Scholar 

  67. A. Jalali, D. A. Morgan, W. I. Sivitz, M. L. Correia, A. L. Mark, and W. G. Haynes, Does leptin cause functional peripheral sympatholysis? Am. J. Hypertens. 14, 615–618 (2001).

    Article  PubMed  CAS  Google Scholar 

  68. J. J. Kuo, O. B. Jones, and J. E. Hall, Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 37, 670–676 (2001).

    PubMed  CAS  Google Scholar 

  69. C. Serradeil-Le Gal, D. Raufaste, G. Brossard, B. Pouzet, E. Marty, J. P. Maffrand, and G. Le Fur, Characterization and localization of leptin receptors in the rat kidney. FEES Lett. 404, 185–191 (1997).

    Article  CAS  Google Scholar 

  70. E. K. Jackson, P. and Li P, Human leptin has natriuretic activity in the rat, Am. J. Physiol. 272, F333–F338 (1997).

    PubMed  CAS  Google Scholar 

  71. D. Villarreal, G. Reams, R. H. Freeman, and A. Taraben, Renal effects of leptin in normotensive, hypertensive, and obese rats. Am. J. Physiol. 275, R2056–R2060 (1998).

    PubMed  CAS  Google Scholar 

  72. J. Beltowski, G. Wjcicka, D. Gomy, and A. Marciniak, Human leptin administered intraperitoneaily stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat–impaired effect in dietary-induced obesity, Med. Set Monit. 8, BR221–BR229 (2002).

    CAS  Google Scholar 

  73. D. Villarreal, G. Reams, and R. H. Freeman, Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats, Kidney Intl. 58, 989–994 (2000).

    Article  CAS  Google Scholar 

  74. G. Wolf, A. Hamann, D. C. Han, U. Helmchen, F. Thaiss, F. N. Ziyadeh, and R. A., Stahl, Leptin stimulates proliferation and TGF-B expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis. Kidney Intl. 56, 860–872 (1999).

    Article  CAS  Google Scholar 

  75. G. Paolisso, M. R. Tagliamonte, M. Galderisi, G. A. Zito, A. Petrocelli, C. Carella, O. de Divitiis, and M. Varricchio, Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men, Hypertension 34, 1047–1052 (1999).

    PubMed  CAS  Google Scholar 

  76. V. Rajapurohitam, X. T. Gan, L. A. Kirshenbaum, and M. Karmazyn, The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes, Circ. Res. 93, 277–279 (2003).

    Article  PubMed  CAS  Google Scholar 

  77. L. A. Barouch, D. E. Berkowitz, R. W. Harrison, et al., Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice., Circulation 108, 754–759 (2003).

    Article  PubMed  CAS  Google Scholar 

  78. M. W. Nickola, L. E. Wold, P. B. Colligan, G. J. Wang, W. K. Samson, and J. Ren, Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO., Hypertension 36, 501–505 (2000).

    PubMed  CAS  Google Scholar 

  79. L. E. Wold, D. P. Relling, I Duan, F. L. Norby, and J. Ren, Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of Jak/STAT pathway. Hypertension 39, 69–74 (2002).

    Article  PubMed  CAS  Google Scholar 

  80. S. Konstantinides, K. Schafer, S. Koschnick, and D. J. Loskutoff, Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity, J.Clin. Invest. 108, 1533–1540 (2001).

    Article  PubMed  CAS  Google Scholar 

  81. P. F. Bodary, R. J. Westrick, K. J. Wickenheiser, Y. Shen, and D. T. Eitzman, Effect of leptin on arterial thrombosis following vascular injury in mice, JAMA 287, 1706–1709 (2002).

    Article  PubMed  CAS  Google Scholar 

  82. I. Maruyama, M. Nakata, and K. Yamaji, Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis, Ann. N. Y. Acad. Sci. 902, 315–319 (2000).

    Article  PubMed  CAS  Google Scholar 

  83. S. Soderberg, T. Olsson, M. Eliasson, O. Johnson, and B. Ahren, Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women, J. Intern. Med. 1999 245, 533–543 (1999).

    Article  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Texas Tech University School of Medicine, Lubbock, Texas, USA

    V. Daniel Castracane PhD (Professor Emeritus and Director of Laboratory Operations) (Professor Emeritus and Director of Laboratory Operations)

  2. Foundation for Blood Research, P. O. Box 190, Scarborough, ME, USA

    V. Daniel Castracane PhD (Professor Emeritus and Director of Laboratory Operations) (Professor Emeritus and Director of Laboratory Operations)

  3. Department of Biological Sciences, Purdue University Calumet, Hammond, Indiana, USA

    Michael C. Henson PhD (Professor and Head) (Professor and Head)

  4. Dept. of Obstetrics and Gynecology, School of Medicine, Tulane University Health Sciences, New Orleans, LA, USA

    Michael C. Henson PhD (Professor and Head) (Professor and Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

(2006). Leptin and Cardiovascular Disease. In: Castracane, V.D., Henson, M.C. (eds) Leptin. Endocrine Updates, vol 25. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-31416-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-31416-7_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-31415-0

  • Online ISBN: 978-0-387-31416-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation